Carmela Rigolino

A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes

K. Komurov, C. Fontanillo, H. Grimes, 2016, Nature Medicine.

Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.

Lesley A. Mathews, M. Ferrer, Noel Southall, 2013, Cancer cell.

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study

R. Latagliata, C. Finelli, F. Morabito, 2012, Annals of Hematology.

degradation of TRAF6 and repression of PSMA1 myeloid leukemia depend on autophagy-mediated lysosomal Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute

G. Jansen, Jing Fang, J. Cloos, 2013 .

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1.

G. Jansen, Jing Fang, J. Cloos, 2012, Blood.